| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | MARA | United States | $9.51 | $919,173,000.00 | Buy | 13 | N/A |
#2 | TME | China | $17.54 | $4,455,416,345.00 | Strong Buy | 6 | 2018 |
#3 | HAYW | United States | $15.80 | $1,099,855,000.00 | Buy | 4 | 2021 |
#4 | SBH | United States | $14.43 | $3,701,424,000.00 | Buy | 5 | 2006 |
#5 | TIMB | Brazil | $19.26 | $4,941,546,695.00 | Buy | 4 | 1998 |
#6 | VIV | Brazil | $11.81 | $10,989,199,704.00 | Buy | 4 | 1998 |
#7 | SOUN | United States | $10.46 | $148,404,000.00 | Buy | 8 | N/A |
#8 | LUMN | United States | $7.61 | $12,690,000,000.00 | Buy | 6 | 1972 |
#9 | WULF | United States | $11.54 | $167,604,000.00 | Strong Buy | 12 | 1995 |
#10 | AMPX | United States | $7.91 | $58,408,000.00 | Strong Buy | 7 | N/A |
#11 | CRVS | United States | $7.82 | $0.00 | Strong Buy | 4 | 2016 |
#12 | VSTM | United States | $7.91 | $13,379,000.00 | Strong Buy | 9 | 2012 |
#13 | OCUL | United States | $12.52 | $55,783,000.00 | Strong Buy | 10 | 2014 |
#14 | OPRX | United States | $12.52 | $109,506,000.00 | Buy | 6 | N/A |
#15 | AURA | United States | $5.64 | $0.00 | Strong Buy | 5 | 2021 |
#16 | NB | United States | $5.50 | $0.00 | Strong Buy | 4 | N/A |
#17 | XGN | United States | $6.08 | $63,599,000.00 | Strong Buy | 6 | 2019 |
#18 | SGMT | United States | $5.93 | $0.00 | Strong Buy | 7 | 2023 |
#19 | DOMO | United States | $8.78 | $318,002,000.00 | Buy | 9 | 2018 |
#20 | GHRS | Ireland | $12.60 | $0.00 | Strong Buy | 9 | 2021 |
#21 | GROY | Canada | $4.06 | $14,464,000.00 | Strong Buy | 5 | 2021 |
#22 | AMLX | United States | $12.12 | -$665,000.00 | Strong Buy | 7 | 2022 |
#23 | LENZ | United States | $16.68 | $17,500,000.00 | Strong Buy | 4 | 2021 |
#24 | YEXT | United States | $8.09 | $447,666,000.00 | Strong Buy | 4 | 2017 |
#25 | MNR | United States | $11.01 | $956,307,000.00 | Strong Buy | 4 | 2023 |
#26 | ELVN | United States | $16.28 | $0.00 | Strong Buy | 4 | 2020 |
#27 | ADCT | Switzerland | $3.54 | $75,209,000.00 | Strong Buy | 6 | 2020 |
#28 | EOSE | United States | $11.60 | $63,458,000.00 | Buy | 7 | N/A |
#29 | COYA | United States | $5.54 | $3,987,706.00 | Strong Buy | 5 | 2022 |
#30 | COUR | United States | $7.38 | $739,774,000.00 | Buy | 12 | 2021 |
#31 | CRBP | United States | $8.13 | $0.00 | Strong Buy | 8 | N/A |
#32 | TDOC | United States | $6.96 | $2,528,199,000.00 | Buy | 14 | 2015 |
#33 | PRME | United States | $3.42 | $5,977,000.00 | Buy | 5 | 2022 |
#34 | CLSK | United States | $10.88 | $766,314,000.00 | Strong Buy | 10 | N/A |
#35 | FDMT | United States | $7.76 | $120,000.00 | Strong Buy | 9 | 2020 |
#36 | OTLY | Sweden | $11.14 | $842,996,000.00 | Buy | 5 | 2021 |
#37 | RARE | United States | $19.25 | $630,598,000.00 | Strong Buy | 15 | 2014 |
#38 | NVTS | United States | $7.30 | $56,598,000.00 | Buy | 6 | N/A |
#39 | ALT | United States | $3.72 | $20,000.00 | Strong Buy | 7 | N/A |
#40 | ORIC | United States | $8.32 | $0.00 | Strong Buy | 12 | 2020 |
#41 | PRCH | United States | $8.98 | $442,483,000.00 | Strong Buy | 9 | N/A |
#42 | JANX | United States | $13.88 | $10,000,000.00 | Strong Buy | 12 | 2021 |
#43 | EH | China | $12.85 | $60,400,607.00 | Strong Buy | 4 | 2019 |
#44 | FRMI | United States | $7.43 | $0.00 | Strong Buy | 7 | 2025 |
#45 | CVRX | United States | $7.34 | $55,969,000.00 | Buy | 7 | 2021 |
#46 | TAC | Canada | $12.69 | $1,783,342,546.00 | Strong Buy | 4 | N/A |
#47 | MLCO | Hong Kong | $7.76 | $5,061,044,000.00 | Buy | 6 | 2006 |
#48 | EVGO | United States | $3.04 | $333,129,000.00 | Buy | 8 | N/A |
#49 | AVAH | United States | $8.39 | $2,290,591,000.00 | Buy | 9 | 2021 |
#50 | VIPS | China | $19.19 | $14,983,370,343.00 | Buy | 4 | 2012 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (December 29, 2025) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.